We propose a new methodology based on standard statistical processes for displaying and rigorously comparing the alloy composition of archaeological bronze alloys. Although traditional approaches using visual comparisons of histograms of alloying elements in an assemblage of archaeological objects are adequate for observing differences between these distributions, we argue that differences in sample size cannot be adequately accounted for without using a statistical approach. We demonstrate this methodology by comparing the alloy composition of bronzes from the sequence of Bronze Age cultures in Central China-Erlitou, Erligang (Zhengzhou, or early Shang), Anyang (late Shang) and Western Zhou. We suggest that this approach allows the identification and rigorous comparison of 'regional alloying practices', which in turn enables us to link the alloy composition of the objects with the intentions and skills of foundry workers.
We report here the rediscovery of the chemical analyses of approximately 540 Chinese bronze objects, carried out in RLAHA in the late 1950s by optical emission spectrometry. Although largely of historical interest, they do in fact even now approximately double the number analyses of Chinese bronze objects that contain data on both major and minor elements. In fact, the other major equivalent data sets, from the Freer Gallery and the Sackler Collection, are of approximately the same vintage. We attempt to evaluate the quality of the data, and address a controversy that appeared in the literature during the 1960s and 1970s about the value of arsenic measurements in Chinese bronzes as an indicator of authenticity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.